The Patent Finder

Taiwan Mitochondrion Applied Technology Co., Ltd.

13 patents currently held · Updated Nov 18, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 2 name spellings.

0
Ending by 2030
Dec 2034
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Jan 9, 2027
    The maintenance fee for Method for improving mitochondria and method for promoting cell division of stem cell (US 10,342,834) comes due Jan 9, 2027. Unpaid by Jul 9, 2027, it lapses early.
  • 1 fee due Mar 24, 2027
    The maintenance fee for Method for treating lung injury and/or diseases related to lung injury (US 10,420,798) comes due Mar 24, 2027. Unpaid by Sep 24, 2027, it lapses early.
  • 1 fee due Jun 3, 2027
    The maintenance fee for Isolated adipose-derived mesenchymal stem cells treated with angelica extract or butylidenephthalide, and wherein the cells have an increased mitochondrial membrane potential and a decreased level of IL-8, and methods for treating parkinson's disease (US 10,493,105) comes due Jun 3, 2027. Unpaid by Dec 3, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 of the patents on this record was granted since Aug 20, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 10,420,798Method for treating lung injury and/or diseases related to lung injury
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,493,105Isolated adipose-derived mesenchymal stem cells treated with angelica extract or butylidenephthalide, and wherein the cells have an increased mitochondrial membrane potential and a decreased level of IL-8, and methods for treating parkinson's disease
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,345,888Method and pharmaceutical composition for continuously maintaining growth of a motor neuron progenitor cell
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,738,871Method of extracting organelles from cells
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,213,467Method for improving mitochondria and method for promoting cell division of stem cell
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,342,834Method for improving mitochondria and method for promoting cell division of stem cell
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,967,019Method for protecting mitochondria in retina cell
In force
 · From the USPTO record
In forceFrom the USPTO record
US 12,429,406Agent for cryopreservation and method for cryopreservation of mitochondria using the same
In force
 · From the USPTO record
In forceFrom the USPTO record
US 12,011,472Use of ramie extract in preparing a composition for improving the activity of mitochondria and improving the activity of telomerase
In force
 · From the USPTO record
In forceFrom the USPTO record
US 12,453,751Use of ramie extract in preparing a composition for improving the activity of mitochondria and improving the activity of telomerase
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 13 patents shown.
Pro members see all 13.
Pro members: see all 13 patents

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

9 pending · 1 abandoned · 5 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited